Intertek opens one of Europe’s largest GMP pharmaceutical stability storage facilities
Intertek, the leading quality solutions provider to industries worldwide, today opened a new 8,000 ft², 190,000 litre pharmaceutical stability storage facility in Royston, UK, in response to increased client demand and enabling the company to broaden the range of solutions it can offer to the global pharmaceutical industry.
Based in Cambridge, the heartland of the UK's pharma and biotech industry, the new pharmaceutical stability storage facility is part of a wider investment programme in Intertek’s global pharmaceutical capabilities. It also complements Intertek’s existing product development services for pharmaceuticals, consumer healthcare, biologics, medical devices and nutraceuticals both in Melbourn and globally. This new facility will enable clients globally to establish recommended and bespoke storage conditions with a state-of-the-art environmental monitoring system.
With the opening of this new Good Manufacturing Practice (GMP)-compliant facility, Intertek, as a leading provider of analytical and formulation support for the pharmaceutical, biotechnology and drug delivery industries, has increased its stability storage capacity significantly, enabling the growing demands for bespoke storage conditions, risk management / contingency storage programs and ‘storage-only’ projects to be met.
For more click here
Source: One nucleus